Myomectomy Market Report 2026

Myomectomy Market Overview

• Myomectomy market size has reached to $1.62 billion in 2025 • Expected to grow to $2.41 billion in 2030 at a compound annual growth rate (CAGR) of 8.1% • Growth Driver: Effect Of Rising Uterine Disorder Prevalence On Myomectomy Market Growth • Market Trend: Next-Generation Imaging-Guided Treatments Enhance Precision And Safety • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Myomectomy Market?

Myomectomy is a surgical procedure designed to remove uterine fibroids (benign growths) while keeping the uterus intact. It helps relieve symptoms such as heavy bleeding, pain, and pressure associated with fibroids. This procedure can also enhance fertility and is often recommended for women who want to preserve their uterus. The main types of myomectomy are abdominal myomectomy, hysteroscopic myomectomy, and laparoscopic myomectomy. Abdominal myomectomy is a surgical procedure to remove fibroids from the uterus through an incision in the abdomen. This method is often chosen when fibroids are large or numerous, as it provides direct access to the uterus. Various products are used, such as laparoscopic power morcellators, harmonic scalpels, laparoscopic sealers, and others, and are used by several end users, including hospitals and clinics, surgical centers, medical device companies, and others.

What Is The Myomectomy Market Growth Forecast?

The myomectomy market size is expected to see strong growth in the next few years. It will grow to $2.41 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing adoption of robotic gynecologic surgeries, rising investments in minimally invasive technologies, growing demand for patient-centric treatment options, expansion of specialized women’s health centers, increasing focus on faster post-surgical recovery. Major trends in the forecast period include increasing adoption of minimally invasive surgical techniques, rising use of robotic-assisted myomectomy procedures, growing preference for fertility-preserving treatments, expansion of advanced surgical instrumentation, enhanced focus on precision surgical outcomes.

Global Myomectomy Market Segmentation

1) By Surgical Approach: Abdominal Myomectomy, Hysteroscopic Myomectomy, Laparoscopic Myomectomy 2) By Product: Laparoscopic Power Morcellators, Harmonic Scalpel, Laparoscopic Sealer, Other Products 3) By End-User: Hospitals And Clinics, Surgical Centers, Other End-Users Subsegments: 1) By Abdominal Myomectomy: Open Abdominal Myomectomy (Laparotomy), Mini-Laparotomy Myomectomy 2) By Hysteroscopic Myomectomy: Resectoscopic Myomectomy, Non-Resectoscopic Techniques 3) By Laparoscopic Myomectomy: Conventional Laparoscopic Myomectomy, Robotic-Assisted Laparoscopic Myomectomy

What Are The Drivers Of The Myomectomy Market?

The rising prevalence of uterine disorders is expected to propel the growth of the myomectomy market going forward. Uterine disorders refer to a range of medical conditions affecting the uterus, including fibroids, endometriosis, and uterine cancer, that can lead to symptoms such as pain, abnormal bleeding, and infertility. The rising prevalence of uterine disorders is attributed to factors such as increased awareness, delayed childbearing, hormonal imbalances, and lifestyle changes. Myomectomy is used in uterine disorders to surgically remove fibroids, alleviating symptoms such as pain, heavy bleeding, and reproductive complications while preserving the uterus. For instance, in May 2025, according to the Cancer Council Victoria, an Australia-based government organization, in 2023, 926 women were diagnosed with uterine cancer, with an incidence rate of 22.3 per 100,000 females, accounting for 2.4% of all cancers diagnosed and 1.2% of all cancer-related deaths in 2023, making uterine cancer the 5th most commonly diagnosed cancer among females in the region that year. Therefore, the rising prevalence of uterine disorders is driving the growth of the myomectomy industry. The growing demand for minimally invasive techniques is expected to propel the growth of the myomectomy market going forward. Minimally invasive surgeries refer to surgical approaches that use small incisions or natural body openings to access and treat internal structures, organs, or tissues to minimize trauma to the patient's body. Minimally invasive techniques provide medical, financial, and aesthetic benefits that appeal to patients and healthcare providers, driving the increasing demand across various medical disciplines. Occlusion devices are medical tools used in minimally invasive procedures to block or close off blood vessels, ducts, or other pathways in the body. These devices are often used in interventional cardiology, radiology, or other fields to treat conditions such as aneurysms, abnormal blood flow, or congenital heart defects. For instance, in January 2024, according to Intuitive Surgical, a US-based medical technology company, in 2023 approximately 2,286,000 surgical procedures were performed worldwide using its da Vinci surgical systems, a 22% increase compared to 2022. Therefore, the growing demand for minimally invasive techniques drives the growth of the myomectomy devices market.

Key Players In The Global Myomectomy Market

Major companies operating in the myomectomy market are Medtronic plc, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Smith & Nephew plc, Hologic Inc., CooperSurgical Inc., Teleflex Incorporated, Karl Storz SE & Co. KG, CONMED Corporation, Richard Wolf GmbH, ERBE Elektromedizin GmbH, LiNA Medical ApS, KLS Martin Group, Aspen Surgical, BOWA Medical, Aesculap AG, Mindray Medical International Limited

Global Myomectomy Market Trends and Insights

Major companies operating in the myomectomy market are focusing on developing innovative solutions, such as next-generation robotic-assisted surgical systems, to meet the rising demand for minimally invasive procedures, improved surgical precision, and faster patient recovery. Robotic-assisted systems are advanced surgical platforms that enhance the surgeon’s capabilities through high-definition 3D visualization, articulating instruments, and precise motion scaling, offering a significant improvement over traditional open or laparoscopic surgeries. For instance, in March 2023, Intuitive Surgical Inc., a U.S.-based medical technology company, launched the da Vinci Xi fifth-generation robotic surgical system, an innovative platform designed to facilitate complex gynecological procedures including myomectomy. The system integrates enhanced imaging, ergonomically designed controls, and multi-quadrant access, allowing surgeons to perform precise dissections with minimal tissue trauma. Its applications include uterine fibroid removal, hysterectomy, and other gynecologic surgeries, providing patients with reduced post-operative pain, shorter hospital stays, and faster recovery.

Regional Outlook

North America was the largest region in the myomectomy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Myomectomy Market?

The myomectomy market consists of revenues earned by entities by providing services such as preoperative evaluation, surgical techniques, anesthesia services, and fertility counseling and follow-up. The market value includes the value of related goods sold by the service provider or included within the service offering. The myomectomy market also includes sales of laparoscopic suturing devices, laparoscopic power morcellators, trocars, and laparoscopes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Myomectomy Market Report 2026?

The myomectomy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the myomectomy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.